|
The Jinling Cohort
RECRUITINGSponsored by Nanjing Shihejiyin Technology, Inc.
Actively Recruiting
SponsorNanjing Shihejiyin Technology, Inc.
Started2022-06-15
Est. completion2027-05-15
Eligibility
Age45 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06011694
Summary
The Jinling Cohort is a prospective, multicenter cohort study in which 15,000 eligible individuals aged 45-75 in Nanjing China will be enrolled.
Eligibility
Age: 45 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria: 1、45-75 years of age; 2、Willing and able to undergo blood sample collection, health questionnaires and annual routine physical exams once a year for three consecutive years; 3、Residents in Nanjing; 4、Fully understand the study and able to provide a written informed consent Exclusion Criteria: 1. Pregnant women; 2. Individuals who have history of cancer or current diagnosis of cancer; 3. Individuals who have organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant; 4. Individulas who have blood transfusion within 30 days prior to the blood draw; 5. Individuals who have an acute infection or inflammation within 14 days prior to the blood draw; 6. Individuals who have taken medication with anti-tumor effects within 30 days prior to the blood draw; 7. Individuals who will not be able to comply with the protocol procedures judged by researchers
Conditions3
CancerLiquid BiopsyMulti Cancer Early Screening
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorNanjing Shihejiyin Technology, Inc.
Started2022-06-15
Est. completion2027-05-15
Eligibility
Age45 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06011694